Health score, competitive moat, risk signals, and key metrics at a glance.
Silicon Laboratories Inc., a fabless semiconductor company, provides mixed-signal analog intensive products in the United States, China, Taiwan, and internationally. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including connected home and security, industrial automation and control, smart metering and agriculture, smart street lighting, renewable energy, electric vehicle supply equipment, industrial wearables and equipment, commercial building automation, consumer electronics, asset tracking, and medical instrumentation; and commercial IoT applications, including smart buildings and lighting, access controls, asset tracking, electronic shelf labels, theft protection, power tools, and enterprise access points. The company's smart home applications comprise smart home cameras, locks, gateways, residential lighting, window shades/blinds, heating, ventilation, air conditioning, switches, smoke/CO detectors, sensors, and home security panels; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking, as well as provides wireless microcontrollers products. It sells its products through its direct sales force, as well as a network of independent sales representatives and distributors. The company was founded in 1996 and is headquartered in Austin, Texas.
Competitive analysis based on 64 quarters of fundamental data
Operating margins are under pressure, averaging -14.2%. The business may lack pricing power or face rising costs.'
ROE is low or negative, suggesting limited competitive advantage or capital allocation challenges.
Data-driven red flags and warnings across 64 quarters
The company posted negative operating margins in recent quarters — core operations are unprofitable.
FCF/Net Income has dropped below 0.7x in 4 quarters — monitor for earnings quality deterioration.
Limited debt-to-equity data available.
Revenue is stable or growing over recent quarters — demand appears durable.
FCF turned negative in 3 of the last 8 quarters — occasional cash consumption.
Shares outstanding rose 2.6% — mild dilution. Compare to earnings growth to assess net per-share impact.
as of April 2026
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
5 of the last 8 quarters generated positive FCF. The company generally funds itself but has occasional cash consumption quarters.
TTM revenue has grown consistently (6 of 7 quarters up), with ~51.3% growth over the period. Strong demand durability.
